AirSculpt's Q3 2025 results reflected a 17.8% year-over-year revenue drop and increased net loss, primarily due to a decline in case volume and impairment charges. Despite these challenges, the company maintained positive adjusted EBITDA and remains optimistic about future market trends and operational efficiencies.
Revenue declined to $34.993 million, down from $42.548 million in Q3 2024.
Net loss widened to $9.512 million compared to $6.040 million in the prior year period.
Case volume decreased by 15.2% year-over-year to 2,780.
Adjusted EBITDA came in at $3.039 million for the quarter.
AirSculpt revised its full-year 2025 revenue and adjusted EBITDA guidance downward to reflect lower-than-expected Q3 performance but emphasized long-term growth prospects supported by operational discipline and GLP-1 market tailwinds.